These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8180826)
1. Type B cholecystokinin receptors on rat glioma C6 cells. Binding studies and measurement of intracellular calcium mobilization. Kaufmann R; Lindschau C; Schöneberg T; Haller H; Henklein P; Boomgaarden M; Ott T Brain Res; 1994 Mar; 639(1):109-14. PubMed ID: 8180826 [TBL] [Abstract][Full Text] [Related]
2. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve. Corp ES; McQuade J; Moran TH; Smith GP Brain Res; 1993 Sep; 623(1):161-6. PubMed ID: 8221086 [TBL] [Abstract][Full Text] [Related]
3. CCKA and CCKB receptors are expressed in small cell lung cancer lines and mediate Ca2+ mobilization and clonal growth. Sethi T; Herget T; Wu SV; Walsh JH; Rozengurt E Cancer Res; 1993 Nov; 53(21):5208-13. PubMed ID: 8221657 [TBL] [Abstract][Full Text] [Related]
4. CCKB receptor activation results in increased [3H]thymidine incorporation in rat glioma C6 cells. Kaufmann R; Henklein P; Nowak G Neuropeptides; 1995 Nov; 29(5):241-4. PubMed ID: 8587658 [TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin induced signaling in rat glioma C6 cells. Kaufmann R; Schöneberg T; Lindschau C; Haller H; Ott T Neuropeptides; 1995 Nov; 29(5):251-6. PubMed ID: 8587660 [TBL] [Abstract][Full Text] [Related]
6. Characterisation of CCKB receptors on GH3 pituitary cells: receptor activation is linked to Ca2+ mobilisation. Smith AJ; Patel S; Freedman SB Eur J Pharmacol; 1994 Apr; 267(2):215-23. PubMed ID: 8050481 [TBL] [Abstract][Full Text] [Related]
7. Cholecystokinin increases intracellular Ca2+ concentration in the Human JURKAT T Lymphocyte cell line. Lignon MF; Bernad N; Martinez J Eur J Pharmacol; 1993 May; 245(3):241-6. PubMed ID: 8335062 [TBL] [Abstract][Full Text] [Related]
8. Comparative 3H-CCK-8S binding studies on CCKB-type receptors in guinea-pig cortex and continuous cell lines. Kaufmann R; Schöneberg T; Henklein P; Boomgaarden M; Sohr D; Ott T Neuropeptides; 1994 Jun; 26(6):429-33. PubMed ID: 7936128 [TBL] [Abstract][Full Text] [Related]
9. Tetronothiodin, a novel CCKB receptor ligand, antagonizes cholecystokinin-induced Ca2+ mobilization in a pituitary cell line. Kuwahara T; Kudoh T; Nagase H; Takamiya M; Nakano A; Ohtsuka T; Yoshizaki H; Arisawa M Eur J Pharmacol; 1992 Oct; 221(1):99-105. PubMed ID: 1459194 [TBL] [Abstract][Full Text] [Related]
10. Binding of cholecystokinin-8 (CCK-8) peptide derivatives to CCKA and CCKB receptors. Schäfer U; Harhammer R; Boomgaarden M; Sohr R; Ott T; Henklein P; Repke H J Neurochem; 1994 Apr; 62(4):1426-31. PubMed ID: 8133271 [TBL] [Abstract][Full Text] [Related]
11. Cholecystokinin B-type receptor signaling is involved in human pancreatic cancer cell growth. Kaufmann R; Schafberg H; Rudroff C; Henklein P; Nowak G Neuropeptides; 1997 Dec; 31(6):573-83. PubMed ID: 9574824 [TBL] [Abstract][Full Text] [Related]
12. CCK-JMV-180 acts as an antagonist of the CCKA receptor in the human IMR-32 neuroblastoma cell line. Schaeffer P; Prabonnaud V; Roux M; Gully D; Herbert JM FEBS Lett; 1994 Nov; 354(2):203-6. PubMed ID: 7957924 [TBL] [Abstract][Full Text] [Related]
13. Characterization of YM022: its CCKB/gastrin receptor binding profile and antagonism to CCK-8-induced Ca2+ mobilization. Saita Y; Yazawa H; Honma Y; Nishida A; Miyata K; Honda K Eur J Pharmacol; 1994 Oct; 269(2):249-54. PubMed ID: 7851501 [TBL] [Abstract][Full Text] [Related]
14. CCKB receptors mediate CCK-8S-induced activation of dorsal hippocampus CA3 pyramidal neurons: an in vivo electrophysiological study in the rat. Gronier B; Debonnel G Synapse; 1995 Oct; 21(2):158-68. PubMed ID: 8584977 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of rebamipide: its cholecystokinin CCK1 receptor binding profile and effects on Ca2+ mobilization and amylase release in rat pancreatic acinar cells. Moon SJ; An JM; Kim J; Lee SI; Ahn W; Kim KH; Seo JT Eur J Pharmacol; 2004 Nov; 505(1-3):61-6. PubMed ID: 15556137 [TBL] [Abstract][Full Text] [Related]
17. Regulation of dopamine D2 receptor affinity by cholecystokinin octapeptide in fibroblast cells cotransfected with human CCKB and D2L receptor cDNAs. Dasgupta S; Li XM; Jansson A; Finnman UB; Matsui T; Rinken A; Arenas E; Agnati LF; Fuxe K Brain Res Mol Brain Res; 1996 Mar; 36(2):292-9. PubMed ID: 8965650 [TBL] [Abstract][Full Text] [Related]
18. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702. Durieux C; Ruiz-Gayo M; Corringer PJ; Bergeron F; Ducos B; Roques BP Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411 [TBL] [Abstract][Full Text] [Related]
19. Effects of guanyl nucleotides on CCKB receptor binding in brain tissue and continuous cell lines: a comparative study. Kaufmann R; Schöneberg T; Henklein P; Meyer R; Martin H; Ott T Neuropeptides; 1995 Jul; 29(1):63-8. PubMed ID: 7566515 [TBL] [Abstract][Full Text] [Related]
20. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors. Zhou W; Povoski SP; Bell RH J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]